FDA calls for heartburn drug Zantac to be pulled from market immediately apple.news/AgWEzbwZFQ-SYb…
The FDA noted that an ongoing investigation has determined that levels of a contaminant in the heartburn medications increase over time and when stored at higher-than-normal temperatures, poses a risk to public health.
The contaminant, N-nitrosodimethylamine or NDMA, is a PROBABLE HUMAN CARCINOGEN and the FDA has been investigating levels of it in ranitidine since the summer of 2019.
